findmyKOL

Udayan Bhatt, MD

Basic profile

The Ohio State University Wexner Medical Center

ORCIDNone on fileNPI
RegionDublin, OH · MidwestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH funding2000–2004Why? →

Udayan Bhatt is a Nephrology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 42 publications with 1,609 citations (h-index 18).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
42publications

Distinct works indexed by OpenAlex.

1,609citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
2NIH grants · 2000–2004

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6700 University Blvd
Dublin, OH 430163508

Telephone

614-293-4837

Provider last certified this registry record 13 Jun 2025.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    67.1%
    Calcium channel blocker14%
    Nifedipine Er63%Amlodipine Besylate31%Diltiazem 24hr Er (Cd)6%
    Part D<11 patients
    Beta blocker9.8%
    Carvedilol78%Metoprolol Succinate22%
    Part D<11 patients

    + 14 more classes in this area

  • Other

    20.3%
    Phosphate Binder11.4%
    Sevelamer Carbonate100%
    Part D42 patients
    Drugs for treatment of hyperkalemia and hyperphosphatemia8.9%
    Velphoro66%Auryxia21%Lanthanum Carbonate13%
    Part D<11 patients
  • Metabolism & gastrointestinal

    5.3%
    Proton pump inhibitor2.3%
    Pantoprazole Sodium62%Omeprazole38%
    Part D<11 patients
    Vitamin D3 Analog2.1%
    Calcitriol100%
    Part D11 patients

    + 1 more class in this area

Where care is delivered (Part B)3.5% facility · 96.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 20002004 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”